BET inhibitors downregulate the expression of the essential lncRNA SMILO in multiple myeloma through regulation of the transcription factor FLI1
Por:
Gomez-Echarte, N, San Jose-Eneriz, E, Carrasco-Leon, A, Barrena, N, Miranda, E, Garate, L, Garcia-Torre, B, Alonso-Moreno, S, Gimenez-Camino, N, Urizar-Compains, E, Olaverri-Mendizabal, D, Aguirre-Ruiz, P, Ariceta, B, Tamariz-Amador, LE, Rodriguez-Otero, P, Planes, FJ, Belver, L, Martin-Subero, JI, Prosper, F and Agirre, X
Publicada:
1 feb 2025
Ahead of Print:
1 feb 2025
Resumen:
Filiaciones:
Gomez-Echarte, N:
Inst Invest Sanit Navarra IDISNA, Ctr Invest Med Aplicada CIMA, Pamplona, Navarra, Spain
Canc Ctr Clin Univ Navarra CCUN, Pamplona, Navarra, Spain
San Jose-Eneriz, E:
Inst Invest Sanit Navarra IDISNA, Ctr Invest Med Aplicada CIMA, Pamplona, Navarra, Spain
Canc Ctr Clin Univ Navarra CCUN, Pamplona, Navarra, Spain
Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain
Carrasco-Leon, A:
Inst Invest Sanit Navarra IDISNA, Ctr Invest Med Aplicada CIMA, Pamplona, Navarra, Spain
Canc Ctr Clin Univ Navarra CCUN, Pamplona, Navarra, Spain
Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain
Barrena, N:
Univ Navarra, TECNUN Escuela Ingn, San Sebastian, Pais Vasco, Spain
Miranda, E:
Inst Invest Sanit Navarra IDISNA, Ctr Invest Med Aplicada CIMA, Pamplona, Navarra, Spain
Canc Ctr Clin Univ Navarra CCUN, Pamplona, Navarra, Spain
Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain
Garate, L:
Canc Ctr Clin Univ Navarra CCUN, Pamplona, Navarra, Spain
Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain
Clin Univ Navarra CUN, Serv Hematol & Terapia Celular, Pamplona, Navarra, Spain
Garcia-Torre, B:
Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain
Alonso-Moreno, S:
Josep Carreras Leukemia Res Inst IJC, Barcelona, Barcelona, Spain
Gimenez-Camino, N:
Inst Invest Sanit Navarra IDISNA, Ctr Invest Med Aplicada CIMA, Pamplona, Navarra, Spain
Canc Ctr Clin Univ Navarra CCUN, Pamplona, Navarra, Spain
Urizar-Compains, E:
Inst Invest Sanit Navarra IDISNA, Ctr Invest Med Aplicada CIMA, Pamplona, Navarra, Spain
Canc Ctr Clin Univ Navarra CCUN, Pamplona, Navarra, Spain
Olaverri-Mendizabal, D:
Univ Navarra, TECNUN Escuela Ingn, San Sebastian, Pais Vasco, Spain
Aguirre-Ruiz, P:
Inst Invest Sanit Navarra IDISNA, Ctr Invest Med Aplicada CIMA, Pamplona, Navarra, Spain
Canc Ctr Clin Univ Navarra CCUN, Pamplona, Navarra, Spain
Ariceta, B:
Inst Invest Sanit Navarra IDISNA, Ctr Invest Med Aplicada CIMA, Pamplona, Navarra, Spain
Canc Ctr Clin Univ Navarra CCUN, Pamplona, Navarra, Spain
Tamariz-Amador, LE:
Canc Ctr Clin Univ Navarra CCUN, Pamplona, Navarra, Spain
Clin Univ Navarra CUN, Serv Hematol & Terapia Celular, Pamplona, Navarra, Spain
Rodriguez-Otero, P:
Canc Ctr Clin Univ Navarra CCUN, Pamplona, Navarra, Spain
Clin Univ Navarra CUN, Serv Hematol & Terapia Celular, Pamplona, Navarra, Spain
Planes, FJ:
Univ Navarra, TECNUN Escuela Ingn, San Sebastian, Pais Vasco, Spain
:
Josep Carreras Leukemia Res Inst IJC, Barcelona, Barcelona, Spain
Catalan Inst Oncol ICO, Canc Therapeut Resistance Program ProCURE, Badalona, Barcelona, Spain
Martin-Subero, JI:
Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain
Inst Catalana Recerca & Estudis Avancats ICREA, Barcelona, Spain
Prosper, F:
Inst Invest Sanit Navarra IDISNA, Ctr Invest Med Aplicada CIMA, Pamplona, Navarra, Spain
Canc Ctr Clin Univ Navarra CCUN, Pamplona, Navarra, Spain
Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain
Clin Univ Navarra CUN, Serv Hematol & Terapia Celular, Pamplona, Navarra, Spain
Agirre, X:
Inst Invest Sanit Navarra IDISNA, Ctr Invest Med Aplicada CIMA, Pamplona, Navarra, Spain
Canc Ctr Clin Univ Navarra CCUN, Pamplona, Navarra, Spain
Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain
Green Submitted, gold
|